...diagnostic procedures and launched it in Europe. The product is a solid-phase assay that uses One Lambda's...
...beads to distinguish complement binding donor-specific antibodies (DSAs) from non-complement binding DSAs. Thermo Fisher acquired One Lambda...

...Fisher will acquire transplant diagnostics company One Lambda for $925 million in cash. Thermo Fisher said One Lambda's...
...human leukocyte antigen (HLA) typing and antibody detection tests will complement its immunosuppressant monitoring assays. One Lambda...
...Fisher, while Wilmer Cutler Pickering Hale and Dorr is legal counsel. Perella Weinberg is advising One Lambda...

...transplant diagnostics company One Lambda Inc. (Canoga Park, Calif.) for $925 million in cash. Thermo Fisher said One Lambda's...
...leukocyte antigen (HLA) typing and antibody detection tests will complement Thermo Fisher's immunosuppressant monitoring assays. One Lambda...
...Fisher, while Wilmer Cutler Pickering Hale and Dorr is legal counsel. Perella Weinberg is advising One Lambda...

...The partners renewed a 2000 deal giving One Lambda rights to use Luminex's xMAP technology to develop...
...SSO to identify HLA alleles (see BioCentury, Nov. 13, 2000). Luminex Corp. (NASDAQ:LMNX), Austin, Texas One Lambda Inc....

...received an upfront payment and will be eligible for royalties. Luminex Corp. (LMNX), Austin, Texas One Lambda Inc....